Milestone Scientific to Present at SeeThruEquity Second Annual Investor Conference Forum in New York
LIVINGSTON, NJ--(Marketwired - May 31, 2013) - Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced that Joseph D'Agostino, Chief Financial Officer & Chief Operating Officer, will present at the upcoming SeeThruEquity Second Annual Investor Conference on June 4, 2013 at 2:30 p.m. Eastern Time at the Penn Club in New York City. A recording of the presentation will be posted on Milestone's website following the conference.
SeeThruEquity, LLC (www.seethruequity.com) is an investment research and corporate access firm producing high quality research on smallcap and microcap companies with less than $1 billion in market capitalization. The firm is focused on delivering an unbiased, institutional quality product to all levels of investors in the investment community and to distribute high impact research for consensus estimates on Thomson Reuters, CapitalIQ, FactSet, Zacks and others as well as to an in-house audience of investors.
About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering advanced computer-controlled drug delivery technologies for the medical and dental markets and currently sells its award-winning products through a global distribution network serving North and South America, Asia, Africa, Europe and the Middle East. For more information on the STA Single Tooth Anesthesia System® instrument and other innovative Milestone products, please visit the Company's web site found at www.milestonescientific.com.
SafeHarbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2012. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
